Alphamab Oncology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	258.82	1,112	1,086	1,069	803.31
Short-Term Investments	1,092	459.35	321.25	247.86	1,128
Trading Asset Securities	-	-	-	33.33	54.01
Cash & Short-Term Investments	1,350	1,571	1,407	1,350	1,985
Cash Growth	-14.07%	11.67%	4.21%	-31.99%	-3.82%
Accounts Receivable	61.95	20.3	7.13	15.49	7.61
Other Receivables	73.35	37.77	65.42	64.03	59.92
Receivables	135.3	58.07	72.55	79.52	67.53
Inventory	107.88	81.81	78.75	64.64	57.91
Other Current Assets	0.28	-	-	-	5.63
Total Current Assets	1,594	1,711	1,559	1,495	2,117
Property, Plant & Equipment	496.32	524.01	576.95	619.74	530.52
Long-Term Accounts Receivable	4.5	-	-	-	-
Other Long-Term Assets	2.46	6.4	1.63	3.26	58.02
Total Assets	2,097	2,242	2,137	2,118	2,705
Accounts Payable	235.49	42.29	31.54	17.63	28.48
Accrued Expenses	-	118.93	119.89	135.36	109.04
Current Portion of Long-Term Debt	33.48	52.26	75	175	449.99
Current Portion of Leases	2.18	2.44	5.5	15.11	13.82
Current Unearned Revenue	9.68	15.48	6.86	13.07	6.38
Other Current Liabilities	0.02	22.64	28.05	28.74	29.55
Total Current Liabilities	280.85	254.04	266.84	384.91	637.26
Long-Term Debt	85.22	129.98	175	150	153.83
Long-Term Leases	2.1	1.27	1.58	5.28	19.63
Long-Term Unearned Revenue	18.01	24.57	21.58	19.67	24.09
Total Liabilities	386.17	409.87	465	559.86	834.8
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	-	4,055	4,053	3,726	3,717
Retained Earnings	-	-2,177	-2,343	-2,132	-1,807
Treasury Stock	-37.12	-9.19	-	-	-
Comprehensive Income & Other	1,748	-37.43	-37.64	-35.85	-39.84
Total Common Equity	1,711	1,832	1,672	1,558	1,870
Shareholders' Equity	1,711	1,832	1,672	1,558	1,870
Total Liabilities & Equity	2,097	2,242	2,137	2,118	2,705
Total Debt	122.98	185.96	257.08	345.39	637.27
Net Cash (Debt)	1,227	1,386	1,150	1,005	1,348
Net Cash Growth	-11.42%	20.46%	14.45%	-25.46%	-26.78%
Net Cash Per Share	1.29	1.41	1.20	1.07	1.44
Filing Date Shares Outstanding	938.81	961.97	964.84	939.72	934.94
Total Common Shares Outstanding	938.81	961.97	964.84	939.72	934.94
Working Capital	1,313	1,457	1,292	1,110	1,479
Book Value Per Share	1.82	1.90	1.73	1.66	2.00
Tangible Book Value	1,711	1,832	1,672	1,558	1,870
Tangible Book Value Per Share	1.82	1.90	1.73	1.66	2.00
Buildings	-	298.2	303.51	285.28	227.4
Machinery	-	397.62	384.82	286.3	152.46
Construction In Progress	-	7.41	0.89	90.83	143.08
Leasehold Improvements	-	6.26	6.26	6.75	1.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.